CBDS Cannabis Sativa Inc

GK Manufacturing Signs Lease on 16,000 Square Foot CBD Mass Production Manufacturing & Co-packing Facility

GK Manufacturing Signs Lease on 16,000 Square Foot CBD Mass Production Manufacturing & Co-packing Facility

Capable Of Producing Up to 12 Million Product Units Per Month

ANAHEIM, CA, March 12, 2020 (GLOBE NEWSWIRE) -- MESQUITE, NV Cannabis Sativa, Inc. (OTCQB:) is proud to announce that its 51% controlled subsidiary, GK Manufacturing & Packaging, Inc. (“GKMP”) , has signed a lease on a 16,364 square foot building in Anaheim, CA. GKMP takes possession later in March­­­. “We are excited to move into a new and substantially larger facility that will be FDA Registered, ISO 9001 Compliant, CGMP Compliant, and Halal/Kosher Certified. The facility is a free-standing building with full HVAC systems, state-of-the-art security, and is capable of producing up to 12 million product units per month”, said Keith Hyatt, of GKMP. David Tobias, CEO of CBDS, added, “we are anxious to complete our move and ramp up our production for our existing customers and for the new customers we will be able to service in the larger facility.”

GKMP offers a full-service co-packing solution for CBD brands with in-house formulations and over 400 product SKUs, as well as label design, in-house printing, and in-house media (offering photo, video, and content creation).

GK Manufacturing has been formulating and manufacturing for more than a dozen years, specializing in unique and specialty products including topicals and beverages. White label services ranging from expert formulation and mixology to packaging and design, along with fulfillment including online orders, warehousing and drop-shipping, are all offered by GKMP. For information, visit the contact page at

About Cannabis Sativa, Inc.:

Cannabis Sativa, Inc. ("CBDS") is engaged in the licensing of cannabis-related intellectual property, marketing and branding for cannabis-based products and services, operation of cannabis-related technology services, and ancillary business activities. CBDS licenses the "hi" and "White Rabbit" brands, holds a U.S. patent on the Ecuadorian Sativa strain of Cannabis, a U.S. Patent for a marijuana lozenge, and operates subsidiaries including: PrestoDoctor® (), GK Manufacturing and Packaging, Inc. ( ), Wild Earth Naturals® (), and iBudtender (). The Company is the official licensee for Virgin Mary Jane Brand (). In addition, CBDS seeks strategic partners for acquisition of operating companies, intellectual property and other assets which fit within the CBDS corporate vision.

Forward-Looking Statements:

This press release contains "forward-looking statements." Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Underlying assumptions include without limitation, the ongoing enactment of legislation favorable to the production of and the commercialization of cannabis products and the Company's success in capitalizing on that legislation. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.

Attachment

Corporate (702) 762-3123
Mailing Address: PO Box 1602, Mesquite, NV 89024
">Corporate (702) 762-3123
Mailing Address: PO Box 1602, Mesquite, NV 89024
EN
12/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cannabis Sativa Inc

 PRESS RELEASE

PrestoDoctor Expands Into Michigan Ahead of New Cannabis Tax Changes

PrestoDoctor Expands Into Michigan Ahead of New Cannabis Tax Changes Strategic market entry positions company for growth as Michigan prepares for 2026 tax reforms Mesquite, NV, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Mesquite, NV — October 21, 2025 — Dogecoin Cash, Inc. (OTCQB: DOGP) subsidiary PrestoDoctor, a national leader in cannabis telehealth and patient-care certification services, today announced its official expansion into the State of Michigan. This move marks a significant step in the company’s strategy to grow its footprint across key regulated cannabis markets, providing telemedi...

 PRESS RELEASE

Dogecoin Cash Inc. (OTCQB:DOGP) Announces Special Distribution of Doge...

Dogecoin Cash Inc. (OTCQB:DOGP) Announces Special Distribution of DogeCoin Cash (MEMECOIN:DOG) to Shareholders MESQUITE, NV, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Mesquite, NV  — Dogecoin Cash Inc. (OTCQB:DOGP) today announced that its Board of Directors has approved a special distribution of DogeCoin Cash (MEMECOIN:DOG) to shareholders of record as of December 15, 2025. The pro rata distribution will be payable on December 22, 2025. Each shareholder of record will receive one DogeCoin Cash (MEMECOIN:DOG) for every share of Dogecoin Cash Inc. (OTCQB:DOGP) common stock held. In total, appr...

 PRESS RELEASE

Dogecoin Cash, Inc. (OTCQB: DOGP) Subsidiary PrestoDoctor Expands Tele...

Dogecoin Cash, Inc. (OTCQB: DOGP) Subsidiary PrestoDoctor Expands Telehealth Cannabis Evaluations to Connecticut, Now Operating in 19 States Nationwide Now Operating in 19 States Nationwide Las Vegas, NV, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Cannabis Evaluations to Connecticut, Now Operating in 19 States Nationwide Mesquite, NV — September 26, 2025 — Dogecoin Cash, Inc. (OTCQB: DOGP today announced that its subsidiary PrestoDoctor, a leading telemedicine platform for medical cannabis evaluations, is expanding services to Connecticut. With this addition, PrestoDoctor now operates i...

 PRESS RELEASE

Dogecoin Cash, Inc. Subsidiary PrestoDoctor Now Accepts Cryptocurrency...

Dogecoin Cash, Inc. Subsidiary PrestoDoctor Now Accepts Cryptocurrency Payments, Including Dogecoin MESQUITE, NV, Sept. 10, 2025 (GLOBE NEWSWIRE) -- September 10, 2025 – Mesquite, NV – Dogecoin Cash, Inc. ($CBDS), a publicly traded leader in blockchain innovation,announced that its wholly owned subsidiary, PrestoDoctor, a leading telemedicine platform for medical cannabis evaluations, has begun accepting  for its services. This includes a wide range of digital assets, with an emphasis on the Company’s namesake coin, Dogecoin (DOGE). This move is part of Dogecoin Cash, Inc.’s broader st...

 PRESS RELEASE

Dogecoin Cash, Inc. Announces PrestoDoctor’s Expansion into Three New ...

Dogecoin Cash, Inc. Announces PrestoDoctor’s Expansion into Three New Markets Arizona, Massachusetts, and Virginia Mesquite, NV, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Dogecoin Cash, Inc. (OTCQB: DOGP), a publicly traded company focused on telehealth services and blockchain-based innovation, today announced that its wholly owned subsidiary, PrestoDoctor,  () has expanded operations into three additional U.S. states: Arizona, Massachusetts, and Virginia, offering access to secure, legally valid online consultations for medical cannabis evaluations. This expansion results in the availability...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch